Research and Markets: European Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2015
November 27 2015 - 6:27AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/z6mr22/2015_european)
has announced the addition of the "2015 European Molecular Blood
Typing, Grouping and Infectious Disease NAT Market report to their
offering.
This comprehensive five-country report is designed to help
current suppliers and potential market entrants identify and
evaluate emerging opportunities in the European molecular blood
banking market during the next five years, and assist industry
executives in developing effective business, new product
development and marketing strategies.
Scope of the Report:
- Explores future marketing and technological trends in major
European countries (France, Germany, Italy, Spain, UK)
- Provides test volume and sales forecasts by market segment/test
location
- Compares features of major automated and semi-automated
molecular and immunohematology analyzers
- Profiles leading and emerging competitors
- Identifies specific product and market opportunities facing
suppliers during the next five years.
Sales and Market Share Analysis:
- Sales and market share estimates for leading suppliers of blood
typing, grouping and infectious disease screening tests by country
and individual product.
Strategic assessments of major suppliers and emerging market
entrants, including their:
- Sales
- M&A
- Product portfolios
- Marketing tactics
- New products in R&D.
Market Segmentation Analysis:
- Market dynamics
- Trends
- Structure
- Size
- Growth
- Key suppliers
Current and Emerging Products:
- Analysis of current and emerging molecular blood typing,
grouping and infectious disease NAT screening assays.
- Review of automated and semi-automated molecular and
immunohematology analyzers.
Technology Review:
- Assessment of current and emerging technologies, and their
potential applications for the blood banking market.
- Comprehensive lists of companies developing or marketing new
technologies and products, by test.
Strategic Recommendations:
- New product development opportunities for molecular blood
typing, grouping and infectious disease NAT assays and
instrumentation with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
For more information visit
http://www.researchandmarkets.com/research/z6mr22/2015_european
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005127/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: In Vitro Diagnostics